karen gaudin

Prof. karen gaudin

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2018 in Molecules
Verified
Journal Article
Open access
PDF file
MYMoussa Yabré
Moussa Yabré
LFLudivine FEREY
Ludivine FEREY
ISIssa Touridomon Somé
Issa Touridomon Somé
KGkaren gaudin
karen gaudin
The greening of analytical methods has gained increasing interest in the field of pharmaceutical analysis to reduce environmental impacts and improve the health safety of analysts. Reversed-phase high-performance liquid chromatography (RP-HPLC) is the most widely used analytical technique involved in pharmaceutical drug development and manufacturing, such as the quality control of bulk drugs and pharmaceutical formulations, as well as the analysis of drugs in biological samples. However, RP-HPLC methods commonly use large amounts of organic solvents and generate high quantities of waste to be disposed, leading to some issues in terms of ecological impact and operator safety. In this context, greening HPLC methods is becoming highly desirable. One strategy to reduce the impact of hazardous solvents is to replace classically used organic solvents (i.e., acetonitrile and methanol) with greener ones. So far, ethanol has been the most often used alternative organic solvent. Others strategies have followed, such as the use of totally aqueous mobile phases, micellar liquid chromatography, and ionic liquids. These approaches have been well developed, as they do not require equipment investments and are rather economical. This review describes and critically discusses the recent advances in greening RP-HPLC methods dedicated to pharmaceutical analysis based on the use of alternative solvents.

1 April 2007 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
MRM. Rakotomanga
M. Rakotomanga
SBS. Blanc
S. Blanc
KGkaren gaudin
karen gaudin
PCPierre Chaminade
Pierre Chaminade
Philippe LoiseauPhilippe Loiseau
Philippe Loiseau
Miltefosine (hexadecylphosphocholine [HePC]) is the first orally active antileishmanial drug. Transient HePC treatment of Leishmania donovani promastigotes at 10 μM significantly reduced the phosphatidylcholine content and enhanced the phosphatidylethanolamine (PE) content in parasite membranes, suggesting a partial inactivation of PE- N -methyltransferase. Phospholipase D activity did not seem to be affected by HePC. In addition, the enhancement of the lysophosphatidylcholine content could be ascribed to phospholipase A2 activation. Moreover, transient HePC treatment had no effect on the fatty acid alkyl chain length or the fatty acid unsaturation rate. Concerning sterols, we found a strong reduction of the C 24 alkylated sterol content, and the enhancement of the cholesterol content could be the result of the HePC condensation effect with sterols. Because some of the effects observed after transient HePC treatment were different from those previously observed in HePC-resistant parasites, it could be hypothesized that continuous in vitro drug pressure induces the mechanisms of regulation in Leishmania lipid metabolism.

15 September 2011 in Rapid Communications in Mass Spectrometry
Verified
Journal Article
Closed access
PDF file
Corinne BureCorinne Bure
Corinne Bure
JCJean‐Luc Cacas
Jean‐Luc Cacas
FWFen Wang
Fen Wang
KGkaren gaudin
karen gaudin
FDFrédéric Domergue
Frédéric Domergue
JSJean‐Marie Schmitter
Jean‐Marie Schmitter

1 October 2008 in Journal of Chromatography A
Verified
Journal Article
Closed access
RRR. Godoy Ramos
R. Godoy Ramos
DLD. Libong
D. Libong
MRM. Rakotomanga
M. Rakotomanga
KGkaren gaudin
karen gaudin
Philippe LoiseauPhilippe Loiseau
Philippe Loiseau
PCPierre Chaminade
Pierre Chaminade

26 January 2016 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
KOKhalid Oumzil
Khalid Oumzil
MRMichael A. Ramin
Michael A. Ramin
CLCyril Lorenzato
Cyril Lorenzato
AHAudrey Hémadou
Audrey Hémadou
JLJeanny Laroche
Jeanny Laroche
PBPhilippe Barthelemy
Philippe Barthelemy

13 February 2021 in Nanomaterials
Verified
Journal Article
Open access
PDF file
TSTarek Saydé
Tarek Saydé
OHOmar El Hamoui
Omar El Hamoui
BBBruno Bruno
Bruno Bruno
KGkaren gaudin
karen gaudin
SBSerge Battu
Serge Battu
GLGaëtane Lespes
Gaëtane Lespes
Three-dimensional cell culture has revolutionized cellular biology research and opened the door to novel discoveries in terms of cellular behavior and response to microenvironment stimuli. Different types of 3D culture exist today, including hydrogel scaffold-based models, which possess a complex structure mimicking the extracellular matrix. These hydrogels can be made of polymers (natural or synthetic) or low-molecular weight gelators that, via the supramolecular assembly of molecules, allow the production of a reproducible hydrogel with tunable mechanical properties. When cancer cells are grown in this type of hydrogel, they develop into multicellular tumor spheroids (MCTS). Three-dimensional (3D) cancer culture combined with a complex microenvironment that consists of a platform to study tumor development and also to assess the toxicity of physico-chemical entities such as ions, molecules or particles. With the emergence of nanoparticles of different origins and natures, implementing a reproducible in vitro model that consists of a bio-indicator for nano-toxicity assays is inevitable. However, the maneuver process of such a bio-indicator requires the implementation of a repeatable system that undergoes an exhaustive follow-up. Hence, the biggest challenge in this matter is the reproducibility of the MCTS and the associated full-scale characterization of this system’s components.